hne health libraries linking evidence with practice

What you need to know:

• Not all facial dermatoses related to personal protective equipment are “maskne”
• Irritant contact dermatitis is the most common cause
• Maintenance of the skin barrier and regular “mask breaks” are important aspects of management, in addition to standard medical treatment of the skin condition

Read BMJ Practice Pointer...
Further content in BMJ...

COVID-19 results in persisting symptoms but there is little systematically collected data estimating recovery time following infection. The authors followed 94% of all COVID-19 cases (n=2904) diagnosed in NSW between January and May 2020 using 3-4 weekly telephone interviews and linkage to hospitalisation and death data to determine if they had recovered from COVID-19 based on symptom resolution. 80% of those with COVID-19 recovered within a month, and 5% continued to experience symptoms 3 months later.
Read more...

Elexacaftor-tezacaftor-ivacaftor is an important therapy for most patients with cystic fibrosis, but its use has been limited to adolescents and adults. This new Practice Changing Update from UpToDate recommends triple therapy (elexacaftor-tezacaftor-ivacaftor) rather than dual therapy (tezacaftor-ivacaftor or lumacaftor-ivacaftor) for patients ≥6 years old with cystic fibrosis who are homozygous for the F508del variant. (Grade 1B recommendation)

UpToDate Cystic fibrosis: treatment with CFTR modulators...
Read original article...

This systematic review and meta-analysis aims to describe the characteristics of the early literature and estimate point prevalence for neurological and neuropsychiatric manifestations of infection with SARS-CoV-2. 13,292 records were screened to identify 215 included studies from 30 countries. Neurological and neuropsychiatric symptoms of COVID-19 in the pandemic’s early phase are varied and common. Symptoms with the highest prevalence were anosmia, weakness, fatigue, dysgeusia, myalgia, depression, headache, anxiety and altered mental status. Heterogeneity for most clinical manifestations was high.
Read article...